196 related articles for article (PubMed ID: 18752063)
1. Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity.
Jahromi LB; Kasari CL; McCracken JT; Lee LS; Aman MG; McDougle CJ; Scahill L; Tierney E; Arnold LE; Vitiello B; Ritz L; Witwer A; Kustan E; Ghuman J; Posey DJ
J Autism Dev Disord; 2009 Mar; 39(3):395-404. PubMed ID: 18752063
[TBL] [Abstract][Full Text] [Related]
2. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
3. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
Sukhodolsky DG; Scahill L; Gadow KD; Arnold LE; Aman MG; McDougle CJ; McCracken JT; Tierney E; Williams White S; Lecavalier L; Vitiello B
J Abnorm Child Psychol; 2008 Jan; 36(1):117-28. PubMed ID: 17674186
[TBL] [Abstract][Full Text] [Related]
4. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ
Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study.
Di Martino A; Melis G; Cianchetti C; Zuddas A
J Child Adolesc Psychopharmacol; 2004; 14(2):207-18. PubMed ID: 15319018
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate for children and adolescents with autism spectrum disorder.
Sturman N; Deckx L; van Driel ML
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011144. PubMed ID: 29159857
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder.
Handen BL; Johnson CR; Lubetsky M
J Autism Dev Disord; 2000 Jun; 30(3):245-55. PubMed ID: 11055460
[TBL] [Abstract][Full Text] [Related]
8. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.
King BH; Hollander E; Sikich L; McCracken JT; Scahill L; Bregman JD; Donnelly CL; Anagnostou E; Dukes K; Sullivan L; Hirtz D; Wagner A; Ritz L;
Arch Gen Psychiatry; 2009 Jun; 66(6):583-90. PubMed ID: 19487623
[TBL] [Abstract][Full Text] [Related]
9. Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.
Pearson DA; Santos CW; Aman MG; Arnold LE; Casat CD; Mansour R; Lane DM; Loveland KA; Bukstein OG; Jerger SW; Factor P; Vanwoerden S; Perez E; Cleveland LA
J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):337-51. PubMed ID: 23782128
[TBL] [Abstract][Full Text] [Related]
10. Methylphenidate an effective treatment for ADHD?
McDougle CJ
J Autism Dev Disord; 2004 Oct; 34(5):593-4. PubMed ID: 15628613
[No Abstract] [Full Text] [Related]
11. Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders.
Scahill L; McDougle CJ; Williams SK; Dimitropoulos A; Aman MG; McCracken JT; Tierney E; Arnold LE; Cronin P; Grados M; Ghuman J; Koenig K; Lam KS; McGough J; Posey DJ; Ritz L; Swiezy NB; Vitiello B;
J Am Acad Child Adolesc Psychiatry; 2006 Sep; 45(9):1114-23. PubMed ID: 16926619
[TBL] [Abstract][Full Text] [Related]
12. Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders.
Reichow B; Volkmar FR; Bloch MH
J Autism Dev Disord; 2013 Oct; 43(10):2435-41. PubMed ID: 23468071
[TBL] [Abstract][Full Text] [Related]
13. A prospective open trial of guanfacine in children with pervasive developmental disorders.
Scahill L; Aman MG; McDougle CJ; McCracken JT; Tierney E; Dziura J; Arnold LE; Posey D; Young C; Shah B; Ghuman J; Ritz L; Vitiello B
J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):589-98. PubMed ID: 17069547
[TBL] [Abstract][Full Text] [Related]
14. [Response With Methylphenidate to ADHD-Like Symptoms in Pervasive Developmental Disorder: Does CES-1 Enzyme Gene Polymorphism Have a Role?].
Akyol Ardıç Ü; Ercan ES; Aygüneş D; Yüce D; Durak S; Kosova B
Turk Psikiyatri Derg; 2017; 28(2):89-94. PubMed ID: 29192941
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological treatment options for autism spectrum disorders in children and adolescents.
Leskovec TJ; Rowles BM; Findling RL
Harv Rev Psychiatry; 2008; 16(2):97-112. PubMed ID: 18415882
[TBL] [Abstract][Full Text] [Related]
16. Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study.
Firestone P; Musten LM; Pisterman S; Mercer J; Bennett S
J Child Adolesc Psychopharmacol; 1998; 8(1):13-25. PubMed ID: 9639076
[TBL] [Abstract][Full Text] [Related]
17. Use of methylphenidate in the treatment of children with autistic disorder.
Quintana H; Birmaher B; Stedge D; Lennon S; Freed J; Bridge J; Greenhill L
J Autism Dev Disord; 1995 Jun; 25(3):283-94. PubMed ID: 7559293
[TBL] [Abstract][Full Text] [Related]
18. Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.
Wigal SB; Wigal T; Schuck S; Brams M; Williamson D; Armstrong RB; Starr HL
J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):121-31. PubMed ID: 21488750
[TBL] [Abstract][Full Text] [Related]
19. Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders.
Ghuman JK; Aman MG; Lecavalier L; Riddle MA; Gelenberg A; Wright R; Rice S; Ghuman HS; Fort C
J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):329-39. PubMed ID: 19702485
[TBL] [Abstract][Full Text] [Related]
20. Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder.
Scahill L; Bearss K; Sarhangian R; McDougle CJ; Arnold LE; Aman MG; McCracken JT; Tierney E; Gillespie S; Postorino V; Vitiello B
J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):125-131. PubMed ID: 27893955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
